Age related macular degeneration Flashcards

1
Q

What is age-related macular degeneration (ARMD)?

A

ARMD is the most common cause of blindness in the UK, characterized by degeneration of the central retina (macula) and usually bilateral changes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the key features of ARMD?

A

ARMD is characterized by degeneration of retinal photoreceptors resulting in the formation of drusen, visible on fundoscopy and retinal photography.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the greatest risk factor for ARMD?

A

Advancing age itself is the greatest risk factor for ARMD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does age affect the risk of ARMD?

A

The risk of ARMD increases threefold for patients older than 75 years compared to those aged 65-74.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does smoking influence the risk of ARMD?

A

Current smokers are twice as likely as non-smokers to have ARMD-related visual loss, and ex-smokers have a slightly increased risk (OR 1.13).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does family history affect the risk of ARMD?

A

First-degree relatives of a sufferer of ARMD are thought to be four times more likely to inherit the condition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are other risk factors for ARMD?

A

Other risk factors include hypertension, dyslipidaemia, and diabetes mellitus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the two traditional forms of macular degeneration?

A

The two forms are dry macular degeneration (90% of cases) and wet macular degeneration (10% of cases).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What characterizes dry macular degeneration?

A

Dry macular degeneration is also known as atrophic and is characterized by drusen, which are yellow round spots in Bruch’s membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What characterizes wet macular degeneration?

A

Wet macular degeneration is also known as exudative or neovascular macular degeneration and is characterized by choroidal neovascularisation, leading to rapid vision loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the clinical features of ARMD?

A

Patients typically present with subacute onset of visual loss, reduction in visual acuity, difficulties in dark adaptation, and fluctuations in visual disturbance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What signs are associated with ARMD?

A

Signs include distortion of line perception on Amsler grid testing and the presence of drusen on fundoscopy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the initial investigation of choice for ARMD?

A

Slit-lamp microscopy is the initial investigation of choice to identify changes affecting the retina.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What investigations are used if neovascular ARMD is suspected?

A

Fluorescein angiography is utilized, often complemented with indocyanine green angiography.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the treatment for dry ARMD according to the AREDS trial?

A

The AREDS trial showed that a combination of zinc with antioxidants A, C, and E reduced disease progression by about one third.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What role does vascular endothelial growth factor (VEGF) play in wet ARMD?

A

VEGF drives increased vascular permeability, and anti-VEGF agents can limit progression and stabilize or reverse visual loss.

17
Q

What are examples of anti-VEGF agents?

A

Examples include ranibizumab, bevacizumab, and pegaptanib, usually administered by 4-weekly injection.

18
Q

What is the risk associated with laser photocoagulation in ARMD treatment?

A

Laser photocoagulation can slow progression but carries a risk of acute visual loss, especially in patients with sub-foveal ARMD.